|
Volumn 6, Issue 1, 2004, Pages
|
Should older adults be screened for cognitive impairment?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
GALANTAMINE;
MEMANTINE;
RIVASTIGMINE;
AGED;
AGING;
ALZHEIMER DISEASE;
ARTICLE;
CLINICAL PRACTICE;
COGNITIVE DEFECT;
DEMENTIA;
DRUG EFFICACY;
EPIDEMIC;
GERIATRIC CARE;
HEALTH CARE POLICY;
HUMAN;
LEWY BODY;
MENTAL TEST;
MINI MENTAL STATE EXAMINATION;
MULTIINFARCT DEMENTIA;
MULTIPLE SCLEROSIS;
PARKINSON DISEASE;
PRIMARY MEDICAL CARE;
SCREENING TEST;
TREATMENT PLANNING;
CLINICAL TRIAL;
FEMALE;
GERIATRIC ASSESSMENT;
MALE;
MASS SCREENING;
METHODOLOGY;
NEUROPSYCHOLOGICAL TEST;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
RISK FACTOR;
AGED;
AGED, 80 AND OVER;
CLINICAL TRIALS;
COGNITION DISORDERS;
DEMENTIA;
FEMALE;
GERIATRIC ASSESSMENT;
HUMANS;
MALE;
MASS SCREENING;
NEUROPSYCHOLOGICAL TESTS;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES;
RISK ASSESSMENT;
RISK FACTORS;
|
EID: 25144453754
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (9)
|